윤덕현 부교수
#림프종#다발골수종#만성림프구백혈병
|
학력
2011 .03 ~ 2012 .02울산대학교 의학 박사
1999 .03 ~ 2003 .02연세대학교 의학 학사
1996 .03 ~ 1998 .02포항공과대학교 생명과학 석사
1991 .03 ~ 1996 .02포항공과대학교 생명과학부 학사
1999 .03 ~ 2003 .02연세대학교 의학 학사
1996 .03 ~ 1998 .02포항공과대학교 생명과학 석사
1991 .03 ~ 1996 .02포항공과대학교 생명과학부 학사
경력
2018 .09 ~ 현재울산의대 서울아산병원 종양내과 부교수
2013 .09 ~ 2018 .08울산의대 서울아산병원 종양내과 조교수
2011 .03 ~ 2013 .08서울아산병원 종양내과 임상전임강사
2009 .03 ~ 2011 .02서울아산병원 전임의
2005 .03 ~ 2009 .02서울아산병원 전공의
2003 .03 ~ 2004 .02세브란스병원 인턴
2013 .09 ~ 2018 .08울산의대 서울아산병원 종양내과 조교수
2011 .03 ~ 2013 .08서울아산병원 종양내과 임상전임강사
2009 .03 ~ 2011 .02서울아산병원 전임의
2005 .03 ~ 2009 .02서울아산병원 전공의
2003 .03 ~ 2004 .02세브란스병원 인턴
논문
Effect of an Arm Traction Device on Image Quality and Radiation Exposure during Neck CT: A Prospective Study.
Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy.
A Randomized Feasibility Study of (18)F-Fluoroestradiol PET to Predict Pathologic Response to Neoadjuvant Therapy in Estrogen Receptor-Rich Postmenopausal Breast Cancer.
Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease.
Clinical characteristics, treatment, and outcome of primary rectal lymphoma: a single center experience of 16 patients.
Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy.
Electrophysiological features of POEMS syndrome compared to MGUS-related neuropathy.
Feasibility of abbreviated cycles of immunochemotherapy for completely resected limited-stage CD20+ diffuse large B-cell lymphoma (CISL 12-09).
GLUT1 as a Prognostic Factor for Classical Hodgkin's Lymphoma: Correlation with PD-L1 and PD-L2 Expression.
Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma.
Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma.
Interim (18)F-FGD PET/CT may not predict the outcome in primary central nervous system lymphoma patients treated with sequential treatment with methotrexate and cytarabine.
PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma.
Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): ...
Primary central nervous system lymphoma: a new prognostic model for patients with diffuse large B-cell histology.
Sequential heart and autologous stem cell transplantation for light-chain cardiac amyloidosis.
Sexual problems in male vs. female non-Hodgkin lymphoma survivors: prevalence, correlates, and associations with health-related quality of life.
The immune checkpoint molecule V-set Ig domain-containing 4 is an independent prognostic factor for multiple myeloma.
The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160).
Treatment outcomes of dose-attenuated CHOP chemotherapy in elderly patients with peripheral T cell lymphoma.
Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy.
A Randomized Feasibility Study of (18)F-Fluoroestradiol PET to Predict Pathologic Response to Neoadjuvant Therapy in Estrogen Receptor-Rich Postmenopausal Breast Cancer.
Beyond first-line non-anthracycline-based chemotherapy for extranodal NK/T-cell lymphoma: clinical outcome and current perspectives on salvage therapy for patients after first relapse and progression of disease.
Clinical characteristics, treatment, and outcome of primary rectal lymphoma: a single center experience of 16 patients.
Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy.
Electrophysiological features of POEMS syndrome compared to MGUS-related neuropathy.
Feasibility of abbreviated cycles of immunochemotherapy for completely resected limited-stage CD20+ diffuse large B-cell lymphoma (CISL 12-09).
GLUT1 as a Prognostic Factor for Classical Hodgkin's Lymphoma: Correlation with PD-L1 and PD-L2 Expression.
Improved prognostic stratification using NCCN- and GELTAMO-international prognostic index in patients with diffuse large B-cell lymphoma.
Increased circulating plasma cells detected by flow cytometry predicts poor prognosis in patients with plasma cell myeloma.
Interim (18)F-FGD PET/CT may not predict the outcome in primary central nervous system lymphoma patients treated with sequential treatment with methotrexate and cytarabine.
PD-L1 expression correlates with VEGF and microvessel density in patients with uniformly treated classical Hodgkin lymphoma.
Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): ...
Primary central nervous system lymphoma: a new prognostic model for patients with diffuse large B-cell histology.
Sequential heart and autologous stem cell transplantation for light-chain cardiac amyloidosis.
Sexual problems in male vs. female non-Hodgkin lymphoma survivors: prevalence, correlates, and associations with health-related quality of life.
The immune checkpoint molecule V-set Ig domain-containing 4 is an independent prognostic factor for multiple myeloma.
The role of frontline autologous stem cell transplantation for primary plasma cell leukemia: a retrospective multicenter study (KMM160).
Treatment outcomes of dose-attenuated CHOP chemotherapy in elderly patients with peripheral T cell lymphoma.
저서
저서 내용이 없습니다.
보도자료
다발골수종 치료 시장서 2차 옵션 키프롤리스 주목
http://www.mdtoday.co.kr/mdtoday/index.html?no=387285
림프종서 맙테라·가싸이바, CHOP 이후 치료 패러다임 주도
http://www.yakup.com/news/index.html?mode=view&cat=14&nid=236432
“비호지킨림프종, 치료 환경 개선 속 여전히 옵션 적어”
http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232320
http://www.mdtoday.co.kr/mdtoday/index.html?no=387285
림프종서 맙테라·가싸이바, CHOP 이후 치료 패러다임 주도
http://www.yakup.com/news/index.html?mode=view&cat=14&nid=236432
“비호지킨림프종, 치료 환경 개선 속 여전히 옵션 적어”
http://www.yakup.com/news/index.html?mode=view&cat=12&nid=232320
포스팅
Characteristics of MYC Gene Aberrations in Multiple Myeloma
The efficacy of systemic high dose methotrexate as central nervous system prophylaxis in patients with high risk diffuse large B-cell lymphoma: A propensity score-matched analysis
A validation study of risk stratification models for diffuse large B-cell lymphoma-not otherwise specified in Korean cohort
A new extranodal scoring system based on the prognostically relevant extranodal sites in diffuse large B-cell lymphoma-not otherwise specified treated with chemoimmunotherapy
A Case of Granulomatous Bone marrow Involvement of Hodgkin lymphoma, Nodular Sclerosis Type
Final Report on Phase II Trial of L-AsparaginasePlus Concurrent ChemoradiotherapyFollowed By Midle(Methotrexate, Ifosfamide, Etoposide, Dexamethasone, and L-asparaginase) Chemotherapy for
Patients with Newly Diagnosed Stage I/II ExtranodalNK/T-Cell L
Clinical outcomes after autologous stem cell transplantation in young multiple myeloma patients with renal impairment
Thiotepa Containing Regimen as Conditioning Chemotherapy for Lymphoma Involving Central Nervous System Compared With BuCyE (Busulfan, Cyclophosphamide and Etoposide)
A New Prognostic Index for Multiple Myeloma Patients in the Era of Novel Agents.
Treatment of primary testicular diffuse large B cell lymphoma without prophylactic intrathecal chemotherapy: a single center experience
Interim PET-CT as a prognostic tool for predicting clinical outcomes in nodal type T-cell non-Hodgkin lymphoma
Peripheral Blood Hematopoietic Progenitor Cell (HPC) Counts at Autologous Stem Cell Collection (ASCC) are Associated with Prognosis in Multiple Myeloma
Two cases of anterior mediastinal mass supported with extracorporeal membrane oxygenation
Can concurrent chemoradiotherapy replace surgery and postoperative radiation in locally advanced stage III/IV tonsillar carcinoma?
High-dose chemotherapy and autologous stem-cell transplantation for Korean patients with relapsed or refractory Hodgkin lymphoma
The role of high dose chemotherapy and autologous stem cell transplantation for relapsed T-cell lymphoma
The efficacy of systemic high dose methotrexate as central nervous system prophylaxis in patients with high risk diffuse large B-cell lymphoma: A propensity score-matched analysis
A validation study of risk stratification models for diffuse large B-cell lymphoma-not otherwise specified in Korean cohort
A new extranodal scoring system based on the prognostically relevant extranodal sites in diffuse large B-cell lymphoma-not otherwise specified treated with chemoimmunotherapy
A Case of Granulomatous Bone marrow Involvement of Hodgkin lymphoma, Nodular Sclerosis Type
Final Report on Phase II Trial of L-AsparaginasePlus Concurrent ChemoradiotherapyFollowed By Midle(Methotrexate, Ifosfamide, Etoposide, Dexamethasone, and L-asparaginase) Chemotherapy for
Patients with Newly Diagnosed Stage I/II ExtranodalNK/T-Cell L
Clinical outcomes after autologous stem cell transplantation in young multiple myeloma patients with renal impairment
Thiotepa Containing Regimen as Conditioning Chemotherapy for Lymphoma Involving Central Nervous System Compared With BuCyE (Busulfan, Cyclophosphamide and Etoposide)
A New Prognostic Index for Multiple Myeloma Patients in the Era of Novel Agents.
Treatment of primary testicular diffuse large B cell lymphoma without prophylactic intrathecal chemotherapy: a single center experience
Interim PET-CT as a prognostic tool for predicting clinical outcomes in nodal type T-cell non-Hodgkin lymphoma
Peripheral Blood Hematopoietic Progenitor Cell (HPC) Counts at Autologous Stem Cell Collection (ASCC) are Associated with Prognosis in Multiple Myeloma
Two cases of anterior mediastinal mass supported with extracorporeal membrane oxygenation
Can concurrent chemoradiotherapy replace surgery and postoperative radiation in locally advanced stage III/IV tonsillar carcinoma?
High-dose chemotherapy and autologous stem-cell transplantation for Korean patients with relapsed or refractory Hodgkin lymphoma
The role of high dose chemotherapy and autologous stem cell transplantation for relapsed T-cell lymphoma
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.